INSULIN LISPRO-AABC: 819 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
819
Total FAERS Reports
5 (0.6%)
Deaths Reported
36
Hospitalizations
819
As Primary/Secondary Suspect
6
Life-Threatening
5
Disabilities
Prescription
Status
FDA Application: 761109 ·
First Report: 20020101 · Latest Report: 20250903
What Are the Most Common INSULIN LISPRO-AABC Side Effects?
#1 Most Reported
Infusion site pain
248 reports (30.3%)
#2 Most Reported
Blood glucose increased
164 reports (20.0%)
#3 Most Reported
Wrong technique in product usage process
115 reports (14.0%)
All INSULIN LISPRO-AABC Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Infusion site pain | 248 | 30.3% | 0 | 0 |
| Blood glucose increased | 164 | 20.0% | 1 | 10 |
| Wrong technique in product usage process | 115 | 14.0% | 0 | 1 |
| Injection site pain | 109 | 13.3% | 0 | 0 |
| Drug ineffective | 84 | 10.3% | 0 | 2 |
| Infusion site erythema | 48 | 5.9% | 0 | 0 |
| Blood glucose decreased | 37 | 4.5% | 0 | 1 |
| Infusion site pruritus | 31 | 3.8% | 0 | 0 |
| Infusion site irritation | 30 | 3.7% | 0 | 0 |
| Blood glucose abnormal | 24 | 2.9% | 0 | 2 |
| Hypoglycaemia | 23 | 2.8% | 0 | 6 |
| Glycosylated haemoglobin increased | 22 | 2.7% | 1 | 1 |
| Hyperglycaemia | 21 | 2.6% | 0 | 3 |
| Nausea | 21 | 2.6% | 1 | 2 |
| Infusion site mass | 20 | 2.4% | 0 | 0 |
| Infusion site haemorrhage | 16 | 2.0% | 0 | 0 |
| Infusion site induration | 16 | 2.0% | 0 | 0 |
| Incorrect dose administered | 15 | 1.8% | 0 | 3 |
| Infusion site reaction | 15 | 1.8% | 0 | 0 |
| Injection site erythema | 15 | 1.8% | 0 | 0 |
Who Reports INSULIN LISPRO-AABC Side Effects? Age & Gender Data
Gender: 52.1% female, 47.9% male. Average age: 53.3 years. Most reports from: US. View detailed demographics →
Is INSULIN LISPRO-AABC Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2002 | 1 | 0 | 1 |
| 2020 | 19 | 0 | 0 |
| 2021 | 55 | 0 | 2 |
| 2022 | 60 | 0 | 1 |
| 2023 | 32 | 0 | 4 |
| 2024 | 45 | 0 | 13 |
| 2025 | 25 | 2 | 1 |
What Is INSULIN LISPRO-AABC Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 489 |
| Type 1 diabetes mellitus | 174 |
| Diabetes mellitus | 104 |
| Type 2 diabetes mellitus | 25 |
| Blood glucose increased | 5 |
INSULIN LISPRO-AABC vs Alternatives: Which Is Safer?
INSULIN LISPRO-AABC vs INSULIN NOS
INSULIN LISPRO-AABC vs INSULIN PORK\INSULIN PURIFIED PORK
INSULIN LISPRO-AABC vs INTERFERON
INSULIN LISPRO-AABC vs INTERFERON ALFA-2A
INSULIN LISPRO-AABC vs INTERFERON ALFA-2A OR INTERFERON ALFA-2B
INSULIN LISPRO-AABC vs INTERFERON ALFA-2B
INSULIN LISPRO-AABC vs INTERFERON BETA
INSULIN LISPRO-AABC vs INTERFERON BETA-1A
INSULIN LISPRO-AABC vs INTERFERON BETA-1B
INSULIN LISPRO-AABC vs INTERFERON GAMMA
Official FDA Label for INSULIN LISPRO-AABC
Official prescribing information from the FDA-approved drug label.